Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Royal Bank of Canada
(NY:
RY
)
115.52
+2.18 (+1.92%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Royal Bank of Canada
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Earnings Outlook For Royal Bank of Canada
February 27, 2024
Via
Benzinga
These High-Flying Artificial Intelligence (AI) Stocks Could Sink 20% or More Over the Next 12 Months, According to Wall Street
February 25, 2024
What goes up just might come down, if analysts are right.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Warrior Met Coal's Ballooning Development Costs Prompt Analysts To Rethink Projections
February 23, 2024
RBC analysts lower price target for Warrior Met Coal to $64 due to higher costs at Blue Creek mine. Capex expected to be $1B in 2024.
Via
Benzinga
Exposures
Coal
What's Going On With Booking Holdings Stock After Earnings?
February 23, 2024
RBC Capital analyst Brad Erickson maintained Booking Holdings with an Outperform and raised the price target from $3550 to $3900, and Wedbush analyst Scott Devitt reiterated Booking Holdings with an...
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
February 23, 2024
Via
Benzinga
Preview: RBC Bearings's Earnings
February 07, 2024
Via
Benzinga
Navigating Discover's Merger With Capital One: Analyst Highlights Opportunities And Challenges Ahead
February 22, 2024
RBC Capital Markets downgrades Discover Financial to Sector Perform with increased price target of $140. Merger with Capital One expected to be accretive and generate $2.7B in synergies. Analyst sees...
Via
Benzinga
Here's How Much You Would Have Made Owning RBC Bearings Stock In The Last 15 Years
February 21, 2024
Via
Benzinga
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
Biohaven's potential with RBC Capital Markets' optimistic outlook.. RBC sees blockbuster potential of $3.2 billion across epilepsy and mood disorders. Anticipate significant developments in lead asset...
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for NMI Holdings: Here's What You Need To Know
February 15, 2024
Via
Benzinga
RBC Illuminates Solar Sector, Launches Coverage For 4 Solar Equipment Leaders
February 14, 2024
RBC Capital Markets highlighted favorable public policy and declining costs within the solar industry and initiated coverage on several solar equipment suppliers, including First Solar, Enphase Energy,...
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
RBC Capital Maintains Outperform Rating for Datadog: Here's What You Need To Know
February 14, 2024
Via
Benzinga
Is HSBC Stock a Buy?
February 14, 2024
The global bank's stock trades at a bargain valuation. With the dividend yield around 5%, is it time to buy?
Via
The Motley Fool
Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month
February 09, 2024
"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins...
Via
Benzinga
RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight
February 09, 2024
IGM Biosciences' strategic shift to immunology with promising bispecific drug, imvotamab. RBC Capital upgraded stock to Outperform, anticipating $21 price target. Data expected in 2H 2024 validates its...
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for Thomson Reuters: Here's What You Need To Know
February 09, 2024
Via
Benzinga
RBC Capital Maintains Outperform Rating for Ensign Group: Here's What You Need To Know
February 06, 2024
Via
Benzinga
Uber, Lyft Can Hitch A Ride Higher If Q4 Earnings Beat Wall Street Estimates
February 05, 2024
Uber reports on Wednesday, while Lyft Q4s are on Feb. 13. RBC has a sector perform rating on Lyft and an outperform rating on Uber.
Via
Benzinga
Topics
Earnings
Exposures
Financial
Capstone Copper Announces Multimillion-Dollar Financing To Support Its Chilean Expansion
February 05, 2024
Capstone Copper Corp. and Orion Mine Finance arranged a CA$375 million bought deal with RBC Capital Markets, expected to close on Feb. 8, 2024.
Via
Benzinga
RBC Capital Maintains Outperform Rating for Reinsurance Gr: Here's What You Need To Know
February 05, 2024
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for Bio-Techne: Here's What You Need To Know
February 02, 2024
Via
Benzinga
RBC Capital Maintains Outperform Rating for Thermo Fisher Scientific: Here's What You Need To Know
February 01, 2024
Via
Benzinga
What's In Store For Clorox This Earnings Season? Analyst Sees Issues With Trash Bags, Cat Litter & More
January 30, 2024
Clorox faces challenges in key product categories like trash bags and cat litter, hindering recovery from the 2023 cyber-attack, according to RBC analyst Nik Modi.
Via
Benzinga
There are signs that NYSE:RY may be ready to breakout.
January 30, 2024
Investors are keeping a close eye on ROYAL BANK OF CANADA (NYSE:RY) as it boasts an impressive technical rating of 7 out of 10, signaling a possible breakout.
Via
Chartmill
'We Stay The Course On Meta And Amazon': Analysts Preview Tech Earnings
January 29, 2024
RBC is looking for acceleration in Amazon's AWS cloud offering and expects increasing adoption of Advantage+ to be a key driver of Meta.
Via
Benzinga
Foresight to Participate in A.G.P’s Virtual Technology Conference
January 29, 2024
--News Direct--
Via
News Direct
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
RBC Capital Maintains Outperform Rating for Popular: Here's What You Need To Know
January 26, 2024
Via
Benzinga
Axsome Depression Drug's Commercial Success, Pipeline Potential Undervalued, Analyst Says
January 25, 2024
Axsome Therapeutics' growth potential with RBC Capital's optimistic coverage. Auvelity's rapid Rx growth projects sales of $296M in 2024, outperforming estimates.
Via
Benzinga
RBC Capital Maintains Outperform Rating for ServiceNow: Here's What You Need To Know
January 25, 2024
Via
Benzinga
RBC Capital Maintains Sector Perform Rating for Procter & Gamble: Here's What You Need To Know
January 24, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.